regulatory
confidence high
sentiment negative
materiality 0.70
Context Therapeutics receives Nasdaq deficiency notice for bid price below $1.00
Context Therapeutics Inc.
- Nasdaq notified Context on July 29, 2026 of non-compliance with Minimum Bid Price Rule (bid below $1.00 for 30 consecutive business days).
- Company has 180 calendar days, until January 25, 2027, to regain compliance by closing at $1.00 or more for 10 consecutive business days.
- If not compliant by Jan 25, 2027, may be eligible for a second 180-day period if it meets other listing standards and notifies Nasdaq of intent to cure.
- Company intends to monitor bid price and evaluate options, but no assurance of regaining compliance or avoiding delisting.